Vident Advisory’s Amicus Therapeutics FOLD Stock Holding History

Vident Advisory’s Portfolio FOLD Stock Details FOLD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$197K	Buy
2025 Q2	$130K	Buy
2025 Q1	$102K	Buy
2024 Q4	–	Sell
2024 Q3	$1.39M	Buy
2024 Q2	$1.08M	Buy
2024 Q1	$943K	Buy
2023 Q4	$948K	Buy
2023 Q3	$196K	Buy